Kenvue

Spun out of Johnson & Johnson with Tylenol, Neutrogena and Band-Aid in tow, Kenvue became the biggest name in consumer health almost overnight - then spent 2025 fending off activists, a CEO exit, an autism-claim firestorm and a $48.7 billion buyout.